Back
ESC Preventive 2024 Premium Access

The effect of atorvastatin on mevalonate levels in blood plasma in patients with coronary heart disease and muscle side effects

Session: Advances in risk stratification and lipid management
Topic: Drug therapy
Speaker: Mrs T. Lauritzen (Drammen, NO)
Event: ESC Preventive Cardiology 2024

Congress Presentation

About the speaker

Mrs Trine Lauritzen

Drammen Hospital, Drammen (Norway)
0 follower

6 more presentations in this session

Unlinking sudden death from coronary artery disease - a systematic scoping review of the association of low-density lipoprotein cholesterol and sudden death

Speaker: Ms R. Beyer (Berlin, DE)

Access
Abstract
Slides
Thumbnail

The association between the remnant cholesterol and non-HDL-C with subclinical carotid atherosclerosis in patients with metabolic syndrome

Speaker: Professor I. Tasic (Nis, RS)

Access
Abstract
Slides
Thumbnail

A polyphenol-rich active substance (TOTUM-070) lowers LDL-cholesterol in subjects with moderate hypercholesterolemia. The OLALIP study

Speaker: Doctor Y. Otero (Perigny, FR)

Access
Abstract
Slides
Thumbnail

Lipoprotein(a) and referrals to a specialist lipid clinic

Speaker: Doctor C. Kennedy (Dublin, IE)

Access
Abstract
Slides
Thumbnail

Lp(a) and vascular inflammation: data from perivascular fat attenuation index measurements

Speaker: Doctor S. Simantiris (Athens, GR)

Access
Abstract
Slides
Thumbnail

Access the full session

Advances in risk stratification and lipid management

Speakers: Mrs T. Lauritzen, Ms R. Beyer, Professor I. Tasic, Doctor Y. Otero, Doctor C. Kennedy...
Access
Thumbnail

About the event

Image

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb